For filings with the FSA include the annex | |||||
For filings with issuer exclude the annex | |||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
SYNCONA LIMITED | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | X | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to the notification obligation: iii |
The Wellcome Trust Limited, as Trustee of The Wellcome Trust |
||||
4. Full name of shareholder(s) (if different from 3.):iv |
North London Ventures Limited |
||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
19 December 2016 | ||||
6. Date on which issuer notified: | 21 December 2016 | ||||
7. Threshold(s) that is/are crossed or reached: vi, vii |
5%, 10%, 15%, 20%, 25%, 30% | ||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
GG00B8P59C08 | 0 | 0 | 243,461,685 | 243,461,685 | 36.98% | |||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
243,461,685 | 36.98% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
The Wellcome Trust Limited as trustee of the Wellcome Trust North London Ventures Limited (243,461,685 voting rights, 36.98%) |
||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will cease to hold: |
||
12. Date on which proxy holder will cease to hold voting rights: |
||
13. Additional information: |
Total voting rights used as a denominator: 658,387,407 |
|
14. Contact name: | Christopher Weston | |
15. Contact telephone number: | 0207 611 8665 | |